Mashreq and Toothpick wire bank loans into 500+ UAE dental clinics

Mashreq Bank and Toothpick launched a digital loan product for healthcare services on 16 April 2026, embedding regulated consumer credit into Toothpick's network of more than 500 UAE dental clinics. Patients can now apply for financing and receive approval within the booking flow, with no paper applications or branch visits.

The out-of-pocket gap this targets

Out-of-pocket healthcare spending in the UAE remains high despite mandatory insurance. The Dubai Health Authority (DHA) reported that dental, dermatology, and elective procedures account for a large portion of uninsured medical costs. Patients regularly face bills of AED 5,000 to AED 50,000 for treatments not covered by standard plans:

• Orthodontics and dental implants
• IVF and fertility treatments
• Cosmetic and elective surgery
• Dermatology procedures outside basic coverage

Buy-now-pay-later products have spread across UAE retail, but healthcare-specific lending has lagged behind. The Mashreq-Toothpick product is the first to place a regulated bank loan, not a BNPL arrangement, directly inside a healthcare booking platform.

What this changes for clinic operators

Toothpick has aggregated more than 500 dental clinics across the UAE. Adding embedded finance turns the platform from a search directory into a transaction layer. Clinic groups that run their own instalment plans now face a competitor that transfers default risk to Mashreq, a bank with total assets above AED 200 billion.

Clinics offering in-house payment plans absorb both default risk and administrative cost. A bank-backed product removes that burden and may increase patient conversion rates. The trade-off: clinics on Toothpick's platform will likely pay referral or processing fees that compress margins on financed procedures.

If the dental vertical works, expansion into fertility clinics, physiotherapy chains, and elective surgery centres is the next logical move. Abu Dhabi's Department of Health (DOH) and the DHA have both flagged patient financial access as a priority, and regulators may prefer bank-embedded lending over unregulated clinic payment plans.

Regulatory and competitive outlook

The UAE Central Bank has tightened oversight of buy-now-pay-later providers since 2024, requiring licensing and consumer protection disclosures. A product structured as a regulated bank loan sidesteps some of that scrutiny while giving consumers clearer terms.

For CFOs at multi-site clinic groups, the question is whether to partner with platforms like Toothpick or build competing financing arrangements with other banks. For CIOs, the integration requirements matter now: embedded lending typically requires API connections between a clinic's practice management system and the lender's disbursement platform.

Mashreq processed more than AED 36 billion in digital transactions in 2025. Healthcare is the latest vertical to receive a dedicated product from the bank's API-based lending infrastructure.

Whether this model scales beyond dental depends on patient default rates and competitive response. If defaults stay low, expect Emirates NBD, FAB, and ADCB to launch similar products within 12 months.